Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor angiogenesis.

G Tobelem1

  • 1Service d'Angiohématologie, Institut des Vaisseaux et du Sang, Hôpital Lariboisière, Paris, France.

Nouvelle Revue Francaise D'Hematologie
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Tumor growth relies on angiogenesis, the formation of new blood vessels. Researchers are identifying new inhibitors of angiogenesis, like cartilage-derived inhibitor and platelet factor 4, to combat cancer progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Did animal offer relevant model for Bevacizumab testing?

British journal of cancer·2008
Same author

[Physiologic and neoplastic angiogenesis].

Journal de chirurgie·2008
Same author

Thrombin induces angiogenesis and vascular endothelial growth factor expression in human endothelial cells: possible relevance to HIF-1alpha.

Journal of thrombosis and haemostasis : JTH·2003
Same author

Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in vivo circulating thrombin.

Thrombosis research·2001
Same author

[Behcet's disease manifested as a intracranial aneurysm].

La Revue de medecine interne·2001
Same author

Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits urokinase/urokinase-receptor expression and MMP-9 secretion by peripheral blood monocytes--a possible protective mechanism against atherothrombosis.

Thrombosis and haemostasis·2000
Same journal

XIVth Congress of the French Society of Hematology. Paris, France, February 3-4, 1995. Abstracts.

Nouvelle revue francaise d'hematologie·1995
Same journal

Improved detection of CD2 on formaldehyde-fixed non dehydrated cells.

Nouvelle revue francaise d'hematologie·1995
Same journal

Engraftment of CD34+ peripheral blood progenitor cells into multiple myeloma patients following total body irradiation.

Nouvelle revue francaise d'hematologie·1995
Same journal

Allogeneic transplantation of peripheral blood progenitor cells.

Nouvelle revue francaise d'hematologie·1995
Same journal

Selection and expansion of CD34+ cells.

Nouvelle revue francaise d'hematologie·1995
Same journal

Ex vivo hematopoietic cell expansion: a theoretical and technological challenge.

Nouvelle revue francaise d'hematologie·1995
See all related articles

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Angiogenesis is crucial for endothelial cell migration, differentiation, and proliferation.
  • Tumor growth and metastasis are dependent on tumor-induced angiogenesis.
  • Several angiogenic factors stimulate endothelial cell proliferation and tube formation.

Purpose of the Study:

  • To review the process of angiogenesis in tumor development.
  • To identify known and novel inhibitors of angiogenesis.
  • To highlight the role of angiogenesis induction in carcinogenesis and metastasis.

Main Methods:

  • Literature review of angiogenesis and its regulators.
  • Identification of known anti-angiogenic compounds.
  • Description of recently identified angiogenesis inhibitors.

Related Experiment Videos

Main Results:

  • Angiogenesis is a key step in tumor development and metastasis.
  • Numerous factors promoting angiogenesis have been identified.
  • Pharmacological compounds like heparin and corticosteroids, along with new inhibitors (cartilage-derived inhibitor, platelet factor 4), exhibit anti-angiogenic properties.

Conclusions:

  • Inhibiting angiogenesis is a potential therapeutic strategy against cancer.
  • The identification of new angiogenesis inhibitors offers promising avenues for cancer treatment.
  • Understanding angiogenesis is vital for developing effective anti-cancer therapies.